4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001104659-24-077868
Director bought 44,032 shares at an average $24.52 ($1,079,575)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HEALY JAMES Director | 2024-07-01 | Purchase | +3,538 | $23.08 | $81,641 | 28,993 | I |
| HEALY JAMES Director | 2024-07-01 | Purchase | +3,565 | $24.21 | $86,316 | 32,558 | I |
| HEALY JAMES Director | 2024-07-01 | Purchase | +4,544 | $25.02 | $113,671 | 37,102 | I |
| HEALY JAMES Director | 2024-07-01 | Purchase | +2,559 | $26.06 | $66,675 | 39,661 | I |
| HEALY JAMES Director | 2024-07-01 | Purchase | +3,799 | $23.08 | $87,664 | 21,660 | I |
| HEALY JAMES Director | 2024-07-01 | Purchase | +3,828 | $24.21 | $92,684 | 25,488 | I |
| HEALY JAMES Director | 2024-07-01 | Purchase | +4,878 | $25.02 | $122,026 | 30,366 | I |
| HEALY JAMES Director | 2024-07-01 | Purchase | +2,748 | $26.06 | $71,599 | 33,114 | I |
| HEALY JAMES Director | 2024-07-01 | Purchase | +3,630 | $23.08 | $83,764 | 29,908 | I |
| HEALY JAMES Director | 2024-07-01 | Purchase | +3,657 | $24.21 | $88,543 | 33,565 | I |
| HEALY JAMES Director | 2024-07-01 | Purchase | +4,661 | $25.02 | $116,598 | 38,226 | I |
| HEALY JAMES Director | 2024-07-01 | Purchase | +2,625 | $26.06 | $68,395 | 40,851 | I |
| Open-market purchases · 44,032 sh · avg $24.52 · $1,079,575 | |||||||
Loading xslF345X05/tm2418922-1_4seq1.xml…